Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 added and the prior Revision: v3.3.3 removed, indicating a small technical update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Location section including California, Texas, Alberta, and Ontario, and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure item.SummaryDifference0.3%

- Check55 days agoChange DetectedPublications notes were updated to state that entries are automatically filled from PubMed and may not pertain to the study, and a Revision: v3.3.2 tag was added. The deletions were adjusted to reflect the same PubMed auto-fill wording, indicating this is a cosmetic update with no change to study data.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new study site: Tainan, Taiwan, 70403. Removed the alternate listing 'Tainan City, Taiwan, 70403' to standardize the location naming.SummaryDifference0.2%

- Check77 days agoChange DetectedNo substantive changes to the study details or data were observed; only minor formatting/layout adjustments appear in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange DetectedAdded a government funding lapse notice and current operating status guidance with a new v3.2.0 release; removed the old v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.